Serif Biomedicines
PrivateLast Round
Early Funding
Apr 21, 2026
Total Funding Raised
$50M
Company Overview
Serif Biomedicines is a biotechnology company pioneering Modified DNA as a new class of medicines, enabling programmable, scalable, durable, and redosable therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Serif Biomedicines Comps
Public and private peers based on sector, stage, and business model.
Serif Biomedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 21, 2026 |
Serif Biomedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Flagship Pioneering | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
$50M raised in early funding round.
Serif Biomedicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Serif Biomedicines's valuation, stock price, and market status.
